TTD | Drug: D0AL0S

Drug General Information
Drug ID	D0AL0S
Former ID	DIB015525
Drug Name	GSK-1362885
Synonyms	1362885
Indication	Type 2 diabetes [ICD9: 250; ICD10:E11]		Discontinued in Phase 1	[522855]
Company	GlaxoSmithKline plc
Target and Pathway
Target(s)	Myophosphorylase	Target Info	Modulator	[1572591]
References
Ref 522855	ClinicalTrials.gov (NCT01013766) A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics. U.S. National Institutes of Health.
Ref 1572591	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

Drug Information